GUILDFORD, UK / ACCESSWIRE / April 19, 2023 / ANGLE plc (AIM:AGL), (OTCQX:ANPCY), a world-leading liquid biopsy company, is delighted to announce it has signed an agreement with BioView Ltd. ("BioView ...
ANGLE AND BIOVIEW TO PRESENT COMBINED SOLUTION FOR CIRCULATING TUMOR CELL DETECTION AND ANALYSIS AT MOLECULAR MED TRI-CON 2020 IN SAN FRANCISCO, 4 MARCH 2020 GUILDFORD, SURREY / ACCESSWIRE / February ...
Hosted on MSN
ANGLE partners with BioView
ANGLE (OTCQX:ANPCY) signs an agreement with BioView to develop a liquid biopsy circulating tumor cell (or CTC) HER2 assay for breast cancer. It will be utilising ANGLE's FDA cleared Parsortix PC1 ...
BioView President and CEO, Dr. Alan Schwebel, commented: "We are excited for this development partnership opportunity with ANGLE, where we plan to leverage the strengths of both our technologies to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results